Clinical Trial Update: A Long-term Follow-up Study of Patients Who Received VOR33

View source ↗

Summary

This update provides long-term follow-up information for patients treated with VOR33, but the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VOR33

Snippet

Sponsor: Vor Biopharma | Conditions: Leukemia, Myeloid, Acute | Status: TERMINATED